The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions based upon inhibition of the RTP801 gene and/or protein.

 
Web www.patentalert.com

< Methods and systems for in silico experimental design and for providing a biotechnology product to a customer

< Method and device for diagnosing and treating insulin-like growth factor deficiency disorders

> Methods and systems for providing a nutraceutical program specific to an individual animal

> Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy
~ 00290